סך נכסים נקיים: Applied Therapeutics (APLT)

Applied Therapeutics (APLT) is implementing "green chemistry" principles to reduce toxic emissions from its laboratories. The company is recruiting experts in orphan pathologies and retaining scientists through stock options, with the indicator standing at 0.00. Small molecule development is conducted in New York, while production is outsourced to CDMO facilities. This chart illustrating the price evolution below demonstrates the price action of this rare disease drug developer.

Book value capitalization reflects the net value of assets minus liabilities, demonstrating the real tangible foundation of the business excluding market speculation. For Applied Therapeutics (APLT), whose stability depends on external financing and clinical trials, the book equity chart serves as a survival indicator, confirming the company's ability to sustain development in the absence of stable operating revenues.